Source link : https://www.newshealth.biz/health-news/first-ever-biologic-approved-for-copd/
The FDA approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic obstructive pulmonary disease (COPD), Sanofi and Regeneron announced on Friday. An injectable interleukin (IL)-4 and IL-13 pathway inhibitor, dupilumab is indicated as an add-on maintenance treatment for inadequately controlled COPD with an eosinophilic phenotype. Primary support for the approval came from […]
Author : News Health
Publish date : 2024-09-27 15:04:56
Copyright for syndicated content belongs to the linked Source.